caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1063678332

Jeremy CotliarM.D.

PRACTICENEW YORK EYEWEAR, INC.See all providers at this practice →
OphthalmologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
764
Unique beneficiaries
—
Total services
861
Distinct HCPCS
11
Medicare payment
$58K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,438 Ophthalmology providers in NY — below median (cohort median 1,869).
REFERRAL NETWORK

Where Jeremy Cotliar's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE NEW YORK AND PRESBYTERIAN HOSPITAL170490
BIO-CHEM TECHNOLOGY LABORATORY, INC.13111
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1120
Laurence Mark
Anesthesiology · New York, NY
1119
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
THE NEW YORK AND PRESBYTERIAN HOSPITAL229625
Quest Diagnostics Incorporated
Clinical Laboratory · Clifton, NJ
2229
Larry Neuman
Internal Medicine · New York, NY
2287
Jason Horowitz
Ophthalmology · New York, NY
1619
Laurence Mark
Anesthesiology · New York, NY
1424
Arthur Cotliar
Ophthalmology · New York, NY
1424
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
12,343
Beneficiaries
—
Total drug cost
$4.0M
Distinct drugs
31
Brand share
50.3%
Top prescribed drugs
Prednisolone Acetate1,439 claims
Latanoprost1,263 claims
Loteprednol Etabonate1,179 claims
Lifitegrast1,081 claims
Cyclosporine1,078 claims
QUALITY · MIPS · 2024
Final MIPS score
98.0
Quality
100.0
Cost
78.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.97%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
78
By payment type
Food and Beverage$2K